Resection of malignant brain tumors in eloquent cortical areas: a new multimodal approach combining 5-aminolevulinic acid and intraoperative monitoring.
暂无分享,去创建一个
Alireza Gharabaghi | Jan Klein | Marina Liebsch | A. Gharabaghi | M. Tatagiba | G. Feigl | R. Ritz | B. Krischek | A. Bornemann | Boris Krischek | J. Klein | Soeren Danz | M. Liebsch | Guenther C Feigl | Antje Bornemann | Kristofer Ramina | Rainer Ritz | Mario Moraes | Marcos S Tatagiba | K. Ramina | Mario Moraes | S. Danz
[1] S. Blond,et al. Prognosis factors of survival time in patients with glioblastoma multiforme: a multivariate analysis of 340 patients , 2007, Acta Neurochirurgica.
[2] Ettore Lettich,et al. Cortical stimulation mapping of language cortex by using a verb generation task: effects of learning and comparison to mapping based on object naming. , 2002, Journal of neurosurgery.
[3] D. Caldiroli,et al. Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma. , 2008, Neuro-oncology.
[4] Mitchel S. Berger,et al. Brain Mapping Techniques to Maximize Resection, Safety, and Seizure Control in Children with Brain Tumors , 1989 .
[5] Susan M. Chang,et al. Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. , 2004, Neuro-oncology.
[6] H. Duffau. Lessons from brain mapping in surgery for low-grade glioma: insights into associations between tumour and brain plasticity , 2005, The Lancet Neurology.
[7] H Stepp,et al. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. , 2000, Journal of neurosurgery.
[8] Hugues Duffau,et al. Intraoperative cortico–subcortical stimulations in surgery of low-grade gliomas , 2005, Expert review of neurotherapeutics.
[9] Jan C Buckner,et al. Factors influencing survival in high-grade gliomas. , 2003, Seminars in oncology.
[10] R. Mirimanoff,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[11] Thomas Pongratz,et al. ALA and malignant glioma: fluorescence-guided resection and photodynamic treatment. , 2007, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.
[12] H Stepp,et al. Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. , 1998, Neurosurgery.
[13] Veit Rohde,et al. EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME: IDENTIFICATION OF AND ADJUSTMENT FOR BIAS , 2008, Neurosurgery.
[14] G. Horstmann,et al. VOLUMETRIC FOLLOW‐UP OF MENINGIOMAS: A QUANTITATIVE METHOD TO EVALUATE TREATMENT OUTCOME OF GAMMA KNIFE RADIOSURGERY , 2007, Neurosurgery.
[15] G von Campe,et al. 5-aminolevulinic acid induced protoporphyrin IX fluorescence in high-grade glioma surgery: a one-year experience at a single institutuion. , 2008, Swiss medical weekly.
[16] Elizabeth Eisenhauer,et al. Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3. , 2008, The Lancet. Oncology.
[17] C. Papagno,et al. INTRAOPERATIVE SUBCORTICAL LANGUAGETRACT MAPPING GUIDES SURGICAL REMOVALOF GLIOMAS INVOLVING SPEECH AREAS , 2007, Neurosurgery.
[18] I. Nagata,et al. USEFULNESS OF INTRAOPERATIVE PHOTODYNAMIC DIAGNOSIS USING 5‐AMINOLEVULINIC ACID FOR MENINGIOMAS WITH CRANIAL INVASION: TECHNICAL CASE REPORT , 2008, Neurosurgery.
[19] F. Zanella,et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. , 2006, The Lancet. Oncology.
[20] M. Papadopoulos,et al. Survival of patients with glioblastoma multiforme has not improved between 1993 and 2004: analysis of 625 cases , 2007, British journal of neurosurgery.